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Abstract 
Several computational models of transport of drugs 
eluted from drug-eluting stents (DES) in curved 
arteries were developed in order to investigate the 
influence of the arterial curvature and complex 
geometries on drug transport in the blood flow and 
in the arterial wall. 
Introduction 
Coronary heart disease (CHD) is the leading cause 
of death in the world. CHD is attributed to 
atherosclerosis, which is characterized by the 
accumulation of lipids and fibrous elements inside 
the arteries causing a progressive reduction in the 
lumen available for blood flow (stenosis). Stent 
implantation has become the most successful 
strategy in the treatment of advanced atherosclerotic 
lesions in arteries. However, in-stent restenosis 
(ISR), a gradual luminal re-narrowing mainly due to 
the vessel wall injury induced by the device, is the 
major clinical limitation of this technique. With the 
advent of drug-eluting stents (DES), the incidence 
of restenosis has been dramatically reduced to less 
than 10%. However, DES do not completely remove 
this problem. Several computational studies have 
been performed in the last decade to investigate 
drug-release and binding mechanisms in arteries, 
but they usually represent simplified straight vessel 
geometries. However, actual arteries, and specially 
coronary arteries, are highly curved vessels. 
Therefore, the main aim of this contribution is to 
analyse the influence of curvature and complex 
geometries on drug transport in the arterial wall. 
Materials and Methods 
We develop several 2D computational models of 
coupled stent drug release and redistribution in the 
arterial wall, similar to that employed by Bozsak et 
al. [1] but with important differences: we consider 
the adventitia as a layer of the model instead of as a 
boundary condition, a curved geometry of the vessel 
and a non-linear saturable reversible reaction model 
in the tissue to describe drug specific binding to 
receptors and drug non-specific binding to general 
extracellular matrix sites [2, 3]. The computational 
geometry consists of an idealized curved segment of 
a coronary artery with ten circular struts embedded 
in the tissue. In the lumen, blood is treated as a 
Newtonian fluid and blood flow is assumed to be 
steady, laminar and incompressible and is modelled 
by steady Navier-Stokes equations. The arterial wall 
is modelled as a multilayer anisotropic porous 
structure distinguishing three different domains: 
subendothelial space (SES), media and adventitia. 
Darcy’s law is used to calculate plasma filtration 
through the porous layers and convection-diffusion-
reaction equations are used to model drug transport 
through blood and the distinct layers of the tissue. 
Endothelium and internal and external elastic 
laminae are considered as semipermeable 
membranes and the flux across them is described by 
Kedem-Katchalsky equations. The majority of DES 
to date have contained either the drug paclitaxel, 
sirolimus or a sirolimus analogue. In this work we 
consider both sirolimus and paclitaxel. The effect of 
the stent struts embedment configuration and stent 
malapposition is also studied in this work. Wherever 
possible, model input parameters were derived from 
experimental data available in the literature. The 
commercial software package COMSOL 
Multiphysics 5.3 (COMSOL AB, Burlington, MA, 
USA) was used to create the computational 
geometry and to solve numerically the partial 
differential equations by means of the finite element 
method (FEM). 
Results 
As example of the obtained results the time-varying 
normalized mean concentration (NMC) profiles of 
paclitaxel in the media layer of the arterial wall for 
the different curvatures studied are shown in Fig. 1. 
These profiles allow observing the different 
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concentration existing in the internal and external 
sides of the artery. 
Conclusions 
The arterial curvature affects the drug concentration 
in the tissue few hours after stent implantation, 
increasing the levels of drug in the internal side of 
the vessel and decreasing in the external one. The 
internal concentration can be increased until two 
times the external one and this ratio is magnified for 
higher curvatures. The stent malaposition, usually 
associated to tortuous vessels, also modified the 
levels of drug in the arterial wall and can affect the 
efficacy of the treatment. 
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FIGURES 
 
Figure 1. Time-varying normalized mean concentration (NMC) profiles of paclitaxel in the media layer of the arterial wall for 
the different curvatures studied in this work. 
